Certara - About the company
Certara is a public company based in Princeton (United States), founded in 2008. It operates as a Provider of a platform for in silico drug discovery and consulting services. Certara has raised an undisclosed amount in funding. The company has 159 active competitors, including 38 funded and 15 that have exited. Its top competitors include companies like Astex Pharmaceuticals, Cartography Biosciences and Inpharmatica.
Company Details
Provider of a platform for in silico drug discovery and consulting services. It has software solutions for molecular modeling and simulation, pharmacokinetic and pharmacodynamic simulation, clinical trial simulators, and scientific informatics. The company provides drug development consulting and medical writing services.
- Website
- certara.com
- Social
- Registered Address
- Princeton, New Jersey
Key Metrics
Founded Year
2008
Location
Princeton, United States
Stage
Public
Latest Funding Round
Ranked
1st among 159 active competitors
Annual Revenue
$100M - $500M as on Dec 31, 2025
Employee Count
1,487 as on Sep 30, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Certara
Certara is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
CERTARA, INC. CIN: 1827090 , United States, Active | Jun 26, 2017 | $100M - $500M (As on Dec 31, 2025) | 1338 (As on Dec 31, 2023) | - |
CERTARA UK LIMITED CIN: 4217235 , United Kingdom, Active | May 14, 2001 | £10M - £50M (As on Dec 31, 2022) | 230 (As on Dec 31, 2022) | |
CERTARA SOFTWARE INDIA PRIVATE LIMITED CIN: U72900KA2012PTC064356 , India, Active | Jun 12, 2012 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | - | |
CERTARA USA, INC. CIN: 510625438 , United States, Active | Dec 26, 999 | - | 568 (As on Dec 31, 2024) | - |
Certara's IPO details
Certara got listed on Dec 11, 2020.
Click here to take a look at Certara's IPO in detail
Sign up to download Certara's company profile
Certara's funding and investors
Certara has raised funding over 6 rounds. Its first funding round was on Dec 19, 2013. Its latest funding round was a Grant (prize money) round on Sep 23, 2021 for $*****. 1 investor participated in its latest round. Certara has 5 institutional investors.
Here is the list of recent funding rounds of Certara:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 23, 2021 | 3581529 | Grant (prize money) | 4919729 | 8984555 | 7590556 | 5753649 |
Jul 27, 2021 | 1164933 | Post IPO | 9725284 | 7634585 | 8025855 | |
Jun 01, 2021 | 3688920 | Grant (prize money) | 4285922 | 6440014 | 4219035 |
Access funding benchmarks and valuations. Sign up today!View details of Certara's funding rounds and investors
Certara's founders and board of directors
Founder? Claim ProfileCertara's employee count trend
Certara has 1,487 employees as of Sep 26. Here is Certara's employee count trend over the years:
Uncover Certara's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Certara's Competitors and alternates
Top competitors of Certara include Astex Pharmaceuticals, Cartography Biosciences and Inpharmatica. Here is the list of Top 10 competitors of Certara, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Certara 2008, Princeton (United States), Public | Provider of a platform for in silico drug discovery and consulting services | - | 67/100 | |
2nd | Astex Pharmaceuticals 1991, Pleasanton (United States), Acquired | Oncology and CNS drug discovery and development using cutting-edge technology | $3M | 64/100 | |
3rd |  Cartography Biosciences 2020, Foster City (United States), Series B | Provider of a platform to discover immunotherapeutics | $124M | 64/100 | |
4th |  Inpharmatica 1998, London (United Kingdom), Acquired | Developer of predictive informatics based platform for drug discovery | $75M | 62/100 | |
5th | Pharmacelera 2015, Barcelona (Spain), Series A | Hardware and software solutions for computer-aided drug design | $7.1M | 59/100 | |
6th | Oxford Drug Design 2001, Oxford (United Kingdom), Series A | Provider of computer-aided design of antibiotics for MDR infections | $12.4M | 59/100 | |
7th | AI-based precision medicine supporting tool for drug discovery | - | 58/100 | ||
8th | Genialis 2015, Boston (United States), Series A | Developer of end-to-end bioinformatics software solutions | $16M | 53/100 | |
9th | CytoReason 2016, Haifa (Israel), Series C | Discovering immune system based drugs by biological data analytics | $130M | 51/100 | |
10th |  PostEra 2019, London (United Kingdom), Series A | AI based molecular designing software for drug discovery | $26.2M | 51/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Certara's competitors? Click here to see the top ones
Certara's Investments and acquisitions
Certara has not made any investments yet. Certara has made 10 acquisitions.Here is the list of latest three $acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 09, 2024 | Acquisition | 1998 | Budapest (Hungary) | |
Dec 13, 2023 | Acquisition | 2013 | Cambridge (United States) | |
Jan 04, 2023 | Acquisition | 2016 | Newburyport (United States) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Certara
Reports related to Certara
Here is the latest report on Certara's sector:
News related to Certara
Filter this listMedia has covered Certara for a total of 19 events in the last 1 year, 8 of them have been about company updates and 1 about partnerships.
•
•
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERTAccess Newswire•Jul 18, 2026•Pomerantz, Certara
•
Does Certara (CERT) Joining the Russell 2000 Recast Its Biosimulation Investment Narrative?Simply Wall St•Jul 01, 2026•Certara
•
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.Newswire•Jun 27, 2026•Pomerantz, Certara
•
•
Certara, Inc. Shareholders Encouraged to Contact Johnson Fistel Regarding Potential Loss RecoveryGlobeNewswire•May 12, 2026•Johnson Fistel, Certara, Bragar Eagel & Squire, Schall Law Firm and 1 other
•
Certara Reports First Quarter 2026 Financial Results and Updates 2026 GuidanceGlobeNewswire•May 11, 2026•Certara
•
Altasciences and Certara announce a strategic partnership to accelerate early drug developmentBusiness Wire•May 08, 2026•Altasciences, Certara
•
Certara Enters Agreement to Sell Regulatory and Medical Writing Business to VeristatGlobeNewswire•Apr 22, 2026•Veristat, Certara
•
Dixon Mitchell Investment Counsel Inc. Purchases Shares of 866,380 Certara, Inc.MarketBeat•Mar 10, 2026•Dixon Mitchell, Certara
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Certara
Explore our recently published companies
- Pro City Supply - Tampa based, 2005 founded, Unfunded company
- Avesdex Unity Bank - Cambridge based, 2026 founded, Unfunded company
- Finova - Kumasi based, 2025 founded, Unfunded company
- Convello - Valsad based, 1998 founded, Unfunded company
- Akshat Green - Patna based, 2025 founded, Unfunded company
- Xunoia - Hyderabad based, 2025 founded, Unfunded company
